Many patients find that once they've adjusted to the medication and lost weight, they actually have more energy than before they started treatment
Don Rauf Author Don Rauf has been a freelance health writer for over 12 years and his writing has been featured in HealthDay, CBS News, WebMD, U.S
News provided by Ro Apr 02, 2026, 13:02 ET The most effective GLP-1 medication is now available in a multi-dose pen NEW YORK, April 2, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform
& Norgren, R
Of that group, more than 70% said they intend to stay on a GLP-1 until they reach their weight loss goal
When it becomes an approved option, retatrutide may be offered as a triple agonist weight loss treatment within a supervised program